Shkreli is accused of looting his former drug company Retrophin to pay off investors he allegedly defrauded at two hedge funds he ran. » Read More
By: Robert Frank
The Senate health-care bill would give the wealthy the biggest tax break in over a decade, according to an analysis. » Read More
By: Dylan Matthews
Here's one idea for universal coverage that doesn't require sudden massive tax increases, says Dylan Matthews. » Read More
By: Bertha Coombs
The large for-profit insurers and hospitals will find ways to grow, whether or not the GOP's health-reform bill is passed this summer. » Read More
A day after the Senate GOP delayed voting on its health-care plan, Trump said that gathering support is "never easy."
'The only thing I'd be impartial about is which prison he goes to,' said one man excused from Shkreli's trial as a would-be juror.
The opioid abuse crisis is growing and addressing it in the GOP health bill could save the entire process, says Jake Novak.
The Senate's Obamacare replacement bill is faring no better with the public than the plan that passed the House earlier this year.
"We don't play a role in drug pricing, but we do affect drug competition," Dr. Scott Gottlieb tells CNBC.
Trump told senators that he would address tax reform later, apparently ignoring the tax pieces of the health-care bill.
The Senate's bill could thin hospitals' margins and wouldn't tackle major issues in health care, said Cleveland Clinic CEO Toby Cosgrove.
Yitzhak Peterburg, interim president and CEO of Teva Pharmaceutical, talks about the disruption facing the traditional health care industry.
Several potential jurors were excused Monday for comments about Shkreli, including "a very evil man," "a snake," or "the price gouger."
The project was shut down for unknown reasons.
AARP calls for Congress to "start from scratch" on a replacement for the Affordable Care Act.
President Donald Trump sounded an optimistic tone after Senate Republicans delayed a vote on their health-care bill.
The FDA's new list — designed to spur generic competition to bring down prices or deter gougers — holds a big risk for Valeant.
The GOP will never be able to pass an Obamacare replacement bill until they do this one thing, says Jake Novak.
More Americans will be left with zero to few insurers selling Obamacare health plans in 2018, CMS said.
If implemented, the Senate Republican health-care bill may actually end up increasing costs compared to Obamacare, says consultant Robert Laszewski.
Get the best of CNBC in your inbox